Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: CT Order (Confidential Treatment Order) SEC Filing

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 08:49 #9219

  • waddlingwillbologni
  • waddlingwillbologni's Avatar Topic Author
  • Visitor
  • Visitor
The lack thereof has crossed my mind several times. NOW we can speculate as to what's being worked on behind closed doors ...

At least they're working on SOMETHING ...

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 08:59 #9220

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3358
  • Thank you received: 1116

waddlingwillbologni wrote: The lack thereof has crossed my mind several times. NOW we can speculate as to what's being worked on behind closed doors ...

At least they're working on SOMETHING ...


:grin:

Definitions from Investopedia :

DEFINITION of 'Confidential Treatment Order - CTO'
An order that provides confidential treatment for certain documents and information, that a company would otherwise have to file. A confidential treatment order (CTO) is issued by the Securities and Exchange Commission (SEC) and may only be in effect for a certain period of time, rather than indefinitely.

BREAKING DOWN 'Confidential Treatment Order - CTO'
Companies would typically seek a CTO in order to keep information that would otherwise put it at a disadvantage, a secret. For example, a company may apply for such an order to keep information regarding a pricing arrangement made with a partner, secret, since competitors finding out this information may go after the partner with a more competitive price.



Read more: Confidential Treatment Order (CTO) www.investopedia.com/terms/c/confidential-treatment-order.asp#ixzz4fAvHfyAJ
Follow us: Investopedia on Facebook

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 09:25 #9221

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 790
  • Thank you received: 103
FAS

This is my speculation, not entirely baseless.

I think the company was closing a certain deal end of the first Q into April. The deal did not close and as as a result the company had to do secondary and the management stock option awards had been reduced (note: the award timing had been delayed relative to the BOD award),

I think the above deal is being delayed till after the STAR data readout with this particular potential partner.

I think CYTX is seeking another partner who has been the runner up, waiting in the wing. CYTX may have sent a letter to the first partner cancelling the deal, while seeking other options. In order words, the company is becoming more aggressive, trying to get things done. In the last 2 weeks, the company has been jerked around, because they has to do a secondary with the deal delay.

Yet, there is another possibility. The secondary offering to the public is partially completed and other actions follow.

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 10:29 #9222

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3358
  • Thank you received: 1116

franshei wrote: FAS

I think the company was closing a certain deal end of the first Q into April. The deal did not close and as as a result the company had to do secondary and the management stock option awards had been reduced (note: the award timing had been delayed relative to the BOD award),

I think the above deal is being delayed till after the STAR data readout with this particular potential partner.


Franshei-

Your speculation is kind of similar to what DOV had in his long letter to his investment buddies on which he copied Rickey.

It probably will be something similar, but could also be very simple....like not having to report 24 weeks data, which should be known by now????? :whistle:

The primary endpoint is the 24 week Cochin score and secondary 24 week Raynaud´s and 24 weeks SHAQ. Of the major endpoints only 48 weeks Cochin is certainly not available and contrary to ACT-OA they do not intend to publish those intermediate data. It beats me, why not. Shareholders own this Company dont they? And they are entitled to interim data if available and they should be available. :evil:

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 10:44 #9223

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2861
  • Thank you received: 204
***Shareholders own this Company dont they?***

I think we just rent it Fas, LOL !

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 11:04 #9224

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 790
  • Thank you received: 103
Yet, there is a third possibility and it happened before with CYTX (departure of Calhoun) and once with GERN (the departure of Okama): the replacement of Hedrick.

Ok, returning to the STAR readout.

BOTOX had some clinical activity in the Raynauld's. Actually in uncontrolled trials, the only two transient (up to about 4 weeks post dose) meaningful clinical response are in pain and in increased blood blood. I think the patients had several repeated dosing early on. Yet in randomized, placebo controlled trials at Hopkins, the treatment arm and the saline controlled arms bear no differences in several parameters. BOXTOX does not have any clinical effects in scleroderma (fingers and lips and other bodily parts).

It is amazing to know that last summer or fall (according to DOV), there was an investors' private meeting in which photos or videos of the phase 1-2 scleroderma trials were shown - dramatic results in all patients except 2 advanced patients, subjects for pending amputation. (Raynaud's happens to scleroderma patients, started before progression into local and diseminated scleroderma ).

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 13:25 #9225

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3358
  • Thank you received: 1116

franshei wrote: Yet, there is a third possibility and it happened before with CYTX (departure of Calhoun) and once with GERN (the departure of Okama): the replacement of Hedrick.


Well- I think that does not require a CTO and should be made public right away and the stock will soar. Anyway- will not happen with family insider man "Rickey" at the helm.

Anyway- on "other"treatments of scleroderma, I do remember that Sildenafil (Viagra) and ACE Inhibitors were used as treatment options too. Since I have experience with both pills and and know they represent a very modest -single- therapeutic action with plenty side effects, the requirements for Scleroderma- reversing fibrotic tissue, blood-flow and immune-modulation/anti-inflammatory will surely be perfectly holistically treated by ADRCs. And I do think that the adoption rates will be much much better than the 3% which are in plans right now.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 14:10 #9226

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 790
  • Thank you received: 103
FAS

In my search for scleroderma and Raynaud's treatments including experimental procedures, I am now convinced that the market size is quite big.

In the case for Raynaud's, the incidents are more common (early stages of scleroderma) than many would think. I am convinced that the CYTX treatment method in this area would work and with FDA approval and insurance coverage, the revenue should be big and bigger than just scleroderma along. Actually, with the scleroderma FDA approval along , plastic surgeons should be able to treat Raynaud's (and covered by insurance).

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 16:02 #9227

  • DOV
  • DOV's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 347
  • Thank you received: 194
Just to clarify a point made- Maxim held an investor day last fall with Marc and Tiago and perhaps others present. They played a video for the crowd of five women who had participated in the Sleredec trial. A month later, I was talking with Marc and learned about the video. Tiago sent me a link and I watched it while on the phone with him. I asked if I could post it here, but Cytori does not own the rights to it and got special permission to show it at Maxim. Jason Kolbert referred to it on a CC, but unless you knew about it, you probably would not have picked up on it.

It was very impressive and it definitely made me feel very good about the coming Star results.
The following user(s) said Thank You: b767cpt

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 24 Apr 2017 22:50 #9228

  • b767cpt
  • b767cpt's Avatar
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 303
  • Thank you received: 4
DOV,
Is this video available for public viewing on YouTube or some other site?
Thanks

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 25 Apr 2017 05:11 #9229

  • sahin
  • sahin's Avatar
  • Offline
  • Junior Boarder
  • Junior Boarder
  • Posts: 20
  • Thank you received: 2
It Looks like the CT order is related to the Azaya acquisition: Exhibit 10.40 in 10-K from 24th of March. Basically, the $ numbers are not defined and only *** are visible, so i think it has nothing to do with the Star Trial...

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
April 24, 2017
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Cytori Therapeutics, Inc.
File No. 001-34375 - CF#34935
_____________________
Cytori Therapeutics, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on March 24, 2017.
Based on representations by Cytori Therapeutics, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.40 through March 15, 2027
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J.

Please Log in or Create an account to join the conversation.

CT Order (Confidential Treatment Order) SEC Filing 25 Apr 2017 08:56 #9230

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3358
  • Thank you received: 1116

sahin wrote: It Looks like the CT order is related to the Azaya acquisition: Exhibit 10.40 in 10-K from 24th of March. Basically, the $ numbers are not defined and only *** are visible, so i think it has nothing to do with the Star Trial...

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
April 24, 2017
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Cytori Therapeutics, Inc.
File No. 001-34375 - CF#34935
_____________________
Cytori Therapeutics, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on March 24, 2017.
Based on representations by Cytori Therapeutics, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.40 through March 15, 2027
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J.


:yep: Somebody who reads 10K´s. Well done Sahin.

Anyway- good guess, but wrong. As a former public accountant I can tell that 10K´s contain the numbers and transactions from 2016 PLUS the IMPORTANT subsequent events from year-end to reporting date, which events (contracts etc )are than added as addendum to the report. The copy for the public can be "starred" i.e. confidential information hidden, which is customary for everybody.

The CTO came almost a month after the 10K so relates to a "current" event what ever it is.
The following user(s) said Thank You: b767cpt

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

CT Order (Confidential Treatment Order) SEC Filing 25 Apr 2017 10:11 #9231

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 790
  • Thank you received: 103
FAS

This web site for CYTX is becoming influential - this morning, Sahin's posting may have dampened the stock price, before moving up with your clarification of the matters.

People are reading.

I want to give credit to Rodney Strong, the old Chuck, who had also indicated that there was a serious partnership discussion leading to possible closing end of the first Q into the second Q. Based on some of the information that I tried to summarize, that deal is now delayed and CYTX may have taken actions to rectify the situation.

In an email from Tiago (within a month), he was quite positive with the pending STAR data readout, "simply based on the known French data". Even if Hedrick knows the real time data from the STAR clinical data, no one at CYTX would say publicly that the STAR data meet expectations statistically. But, one should evaluate other medical information online, relative to what is known re what is known in the CYTX treatment and make an assessment -my assessment is also very positive.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.093 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites